Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

Company Balance Sheet At 30 June 2012

Note2012
£'000
2011
£'000
Fixed assets
Investmentsiii251,104132,119
Intangible assetsiv4,901
256,005132,119
Current assets
Debtors (includes amounts falling due after more than one year of £571,000(2011: £2,417,000))v21,30639,873
Cash at bank and in hand1,0522
22,35839,875
Creditors: amounts falling due within one yearvi(35,916)(43,866)
Net current liabilities(13,558)(3,991)
Total assets less current liabilities242,447128,128
Creditors: amounts falling due after more than one yearvi(113,800)(55,746)
Net assets128,64772,382
Capital and reserves
Called up share capitalix869664
Share premium accountx122,64263,559
Hedging reservex(286)(294)
Profit and loss accountx5,4228,453
Total equity Shareholders' funds128,64772,382

The financial statements were approved by the Board of Directors on 4 September 2012 and are signed on its behalf by:

Ian Page
Chief Executive
4 September 2012

Simon Evans
Group Finance Director
4 September 2012

Company number: 3369634

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.